- India’s Waqf Policy Shift: How AI Can Drive Transparency & Growth
- Fitch: Nigerian Bank Ratings Sensitive to Sovereign, Operating Environment
- Shaping the Future of Banking in Southern Africa: Innovation, Connectivity, and Financial Resilience
- BRVM Investment Days returns to London
- The 20th Edition Connected Banking Summit - Innovation & Excellence Awards 2025
French Drugs Maker Targets Africa With Nigerian Acquisition
LAGOS (Capital Markets in Africa) – Biogaran SAS, a closely held French pharmaceuticals manufacturer, plans to tap into Nigeria’s $1.3 billion drugs market as a launchpad for its expansion into Africa, company President Pascal Briere said. The unit of France’s second-largest drug maker, Les Laboratoires Servier, last month acquired Nigeria’s Swipha Limited. after an initial $500,000 investment. Biogaran expects Nigeria’s pharmaceuticals industry to grow by more than 12 percent annually. “We found that Nigeria is well adapted for what we…
Read More